secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-06-05T23:59:59+00:00
Accession:  0001193125-24-154675
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aileron sets 2024 annual meeting for Aug 20; shareholder proposals due June 15
------------------------------------------------------------------------------

- Annual meeting date changed to August 20, 2024, more than 30 days from last year's anniversary.
- Deadline for Rule 14a-8 stockholder proposals is June 15, 2024.
- Deadline for director nominations under bylaws is also June 15, 2024.
- Proposals must comply with bylaws and SEC rules to be considered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524154675/0001193125-24-154675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524154675/d839689d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-154675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer